These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 6388612)

  • 1. Captopril in heart failure. A double blind controlled trial.
    Cleland JG; Dargie HJ; Hodsman GP; Ball SG; Robertson JI; Morton JJ; East BW; Robertson I; Murray GD; Gillen G
    Br Heart J; 1984 Nov; 52(5):530-5. PubMed ID: 6388612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin converting enzyme inhibition in heart failure.
    Cleland JG; Dargie HJ; Robertson JI
    Br J Clin Pharmacol; 1984; 18 Suppl 2(Suppl 2):157S-160S. PubMed ID: 6099732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Captopril in heart failure: a double-blind study of the effects on renal function.
    Cleland JG; Dargie HJ; Gillen G; Robertson I; East BW; Ball SG; Morton JJ; Robertson JI
    J Cardiovasc Pharmacol; 1986; 8(4):700-6. PubMed ID: 2427807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of enalapril in heart failure: a double blind study of effects on exercise performance, renal function, hormones, and metabolic state.
    Cleland JG; Dargie HJ; Ball SG; Gillen G; Hodsman GP; Morton JJ; East BW; Robertson I; Ford I; Robertson JI
    Br Heart J; 1985 Sep; 54(3):305-12. PubMed ID: 2994698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vasodilatation with captopril and prazosin in chronic heart failure: double blind study at rest and on exercise.
    Bayliss J; Canepa-Anson R; Norell MS; Poole-Wilson P; Sutton G
    Br Heart J; 1986 Mar; 55(3):265-73. PubMed ID: 3513808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Long-term treatment of chronic heart failure by an inhibitor of angiotensin converting enzyme].
    Komajda M; Eugène M; Evans J; Laurenceau JL; Hubermann JP; Thomas D; Drobinski G; Leprince JL; Ganty J; Wajman A; Guedj D; Grosgogeat Y
    Arch Mal Coeur Vaiss; 1983 Jan; 76(1):29-36. PubMed ID: 6303239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peripheral haemodynamic effects of inhibition of prostaglandin synthesis in congestive heart failure and interactions with captopril.
    Townend JN; Doran J; Lote CJ; Davies MK
    Br Heart J; 1995 May; 73(5):434-41. PubMed ID: 7786658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of captopril on serum digoxin and urinary urea and digoxin clearances in patients with congestive heart failure.
    Cleland JG; Dargie HJ; Pettigrew A; Gillen G; Robertson JI
    Am Heart J; 1986 Jul; 112(1):130-5. PubMed ID: 3524169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term treatment of severe chronic heart failure with captopril: a double-blind, randomized, placebo-controlled, long-term study.
    Bussmann WD; Störger H; Hadler D; Reifart N; Fassbinder W; Jungmann E; Kaltenbach M
    J Cardiovasc Pharmacol; 1987; 9 Suppl 2():S50-60. PubMed ID: 2441202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Converting-enzyme inhibitor therapy for chronic heart failure.
    Massie BM; Kramer BL; Topic N
    Herz; 1983 Apr; 8(2):71-80. PubMed ID: 6343210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term treatment of congestive heart failure with captopril.
    Komajda M; Eugene M; Evans J; Drobinski G; Laurenceau JL; Grosgogeat Y
    Br J Clin Pharmacol; 1982; 14 Suppl 2(Suppl 2):223S-229S. PubMed ID: 6753904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haemodynamic and neurohumoral response to exercise in patients with congestive heart failure treated with captopril.
    Creager MA; Faxon DP; Weiner DA; Ryan TJ
    Br Heart J; 1985 Apr; 53(4):431-5. PubMed ID: 3885981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sustained effectiveness of converting-enzyme inhibition in patients with severe congestive heart failure.
    Dzau VJ; Colucci WS; Williams GH; Curfman G; Meggs L; Hollenberg NK
    N Engl J Med; 1980 Jun; 302(25):1373-9. PubMed ID: 6246425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Captopril: an update review of its pharmacological properties and therapeutic efficacy in congestive heart failure.
    Romankiewicz JA; Brogden RN; Heel RC; Speight TM; Avery GS
    Drugs; 1983 Jan; 25(1):6-40. PubMed ID: 6218982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of captopril in acute and chronic heart failure. Correlations with plasma levels of noradrenaline, renin, and aldosterone.
    Wenting GJ; Man in't veld AJ; Woittiez AJ; Boomsma F; Laird-Meeter K; Simoons ML; Hugenholtz PG; Schalekamp MA
    Br Heart J; 1983 Jan; 49(1):65-76. PubMed ID: 6336940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A placebo-controlled trial of captopril in refractory chronic congestive heart failure. Captopril Multicenter Research Group.
    J Am Coll Cardiol; 1983 Oct; 2(4):755-63. PubMed ID: 6350401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical importance of the renin-angiotensin system in chronic heart failure: double blind comparison of captopril and prazosin.
    Bayliss J; Norell MS; Canepa-Anson R; Reid C; Poole-Wilson P; Sutton G
    Br Med J (Clin Res Ed); 1985 Jun; 290(6485):1861-5. PubMed ID: 3924285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Acute and long-term effect of captopril in severe chronic heart failure].
    Kikis D; Heck I; Stumpe KO; Esser H
    Dtsch Med Wochenschr; 1985 Apr; 110(15):583-8. PubMed ID: 2983968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prognosis of mild chronic heart failure: effects of the ACE inhibitor captopril].
    Kleber FX; Doering W
    Herz; 1991 Sep; 16 Spec No 1():283-93. PubMed ID: 1820294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of captopril on renal function in patients with congestive heart failure.
    Pierpont GL; Francis GS; Cohn JN
    Br Heart J; 1981 Nov; 46(5):522-7. PubMed ID: 7032555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.